Voisin et al., found that a cholesterol metabolite, 6-oxo-cholestan-3β,5α-diol (OCDO), induces breast cancer proliferation through GR activation and the proliferative effect of OCDO is completely attenuated by a potent GR inhibitor [25]. The gene discussed is NR3C1; the disease is breast cancer.